[ET Net News Agency, 30 May 2025] FOSUN PHARMA (02196) rose 10.2% to HK$16.48.
It hits an intra-day high of HK$16.5, hitting an 1-month high, and an intra-day low of HK$15.28. The total shares traded was 24.67 million, with a value of HK$393.83m. The active buy/sell ratio is 70:30, with net buying turnover of HK$151.23m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$8m, with volume weighted average price of HK$15.945. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$57.8m, with volume weighted average price of HK$15.954. The stock has risen a combined 14.8% over the past 2 consecutive trading days.
Basic Information| Nominal | 16.480 | % Chg | +10.16% |
| High | 16.500 | Low | 15.280 |
| Shares Tr | 24.67m | Turnover | 393.83m |
| 10-D SMA | 14.584 | %H.V | 29.598 |
| 20-D SMA | 14.263 | VWAP | 15.963 |
| 50-D SMA | 14.537 | RSI14 | 73.106 |
Status: Hitting an 1-month high, active buy/sell ratio is 70:30, with net buying turnover of HK$151.23m, rising a combined 14.8% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| FOSUN PHARMA (02196) | 16.48 | +10.16 |
| SIHUAN PHARM (00460) | 0.97 | +2.11 |
| GRAND PHARMA (00512) | 8.71 | -0.11 |
| SINO BIOPHARM (01177) | 4.44 | +0.45 |
| HENGRUI PHARMA (01276) | 57.60 | +0.17 |
| LIVZON PHARMA (01513) | 29.15 | +1.04 |
| LUYE PHARMA (02186) | 2.55 | +4.51 |
| SH PHARMA (02607) | 11.52 | +0.52 |
| CHINARES PHARMA (03320) | 5.16 | -0.19 |
| HANSOH PHARMA (03692) | 25.80 | -0.96 |
(ed)
Nominal 